Key facts
- Lupin Limited received U.S. FDA approval for Ranluspec™ injection.
- Ranluspec™ is a ranibizumab injection.
- The approval was announced on June 4, 2026.
Lupin Limited announced on June 4, 2026, that the United States Food and Drug Administration (U.S. FDA) has approved its ranibizumab injection, Ranluspec™. This approval signifies a key advancement for the global pharmaceutical company within the U.S. market.